Recommended Format for Writing a Diagnosis of Systemic Lupus Erythematosus (SLE) on a Patient's Chart
When documenting a diagnosis of SLE on a patient's chart, include the disease name, specific organ involvement, disease activity status, and relevant laboratory findings to ensure proper monitoring and treatment. 1
Essential Components of SLE Documentation
Primary Diagnosis
- Document "Systemic Lupus Erythematosus (SLE)" as the primary diagnosis 1
- Include date of initial diagnosis if available 1
Specific Organ Involvement
- Document all affected organ systems with specific manifestations:
- Mucocutaneous: Specify as LE-specific, LE non-specific, LE mimickers, or drug-related 1
- Musculoskeletal: Document type and location of arthritis 1
- Renal: Include nephritis classification if biopsy performed 1
- Neuropsychiatric: Specify manifestations (seizures, cognitive impairment, etc.) 1
- Hematologic: Document specific cytopenias 1, 2
- Other organ involvement: Cardiopulmonary, gastrointestinal, etc. 1
Disease Activity Status
- Clearly state current disease activity: active, inactive, or in remission 1
- Document any recent flares with dates 1
- Include validated disease activity measures when available 1
Laboratory Findings
- Include relevant autoantibody profile:
- ANA (titer and pattern)
- Anti-dsDNA
- Anti-Ro/SSA, Anti-La/SSB
- Anti-Sm, Anti-RNP
- Antiphospholipid antibodies 1
- Document complement levels (C3, C4) 1
- Include other relevant laboratory abnormalities (CBC, renal function, urinalysis) 1
Current Treatment
- List all current medications with dosages 1
- Document hydroxychloroquine status (as it's standard of care) 2
- Include immunosuppressive agents if used 1, 2
Sample Format
Diagnosis: Systemic Lupus Erythematosus (SLE)
- Date of diagnosis: [Date]
- Current status: [Active/Inactive/Remission]
- Organ involvement:
* Mucocutaneous: [Specific lesions]
* Renal: [Lupus nephritis class if known]
* Musculoskeletal: [Arthritis details]
* Neuropsychiatric: [Specific manifestations]
* Other: [Additional organ involvement]
- Laboratory findings:
* ANA: [Titer and pattern]
* Anti-dsDNA: [Positive/Negative, value]
* Complement: C3 [value], C4 [value]
* Other relevant antibodies: [Results]
- Current treatment: [Medications with doses]Important Considerations
Monitoring Parameters
- Include parameters that require regular monitoring:
Disease Damage
- Document accumulated organ damage from disease or treatment 1
- Include comorbidities related to SLE or its treatment 1
Common Pitfalls to Avoid
- Avoid documenting only "SLE" without specifying organ involvement, as this may lead to inadequate monitoring 1
- Don't omit current disease activity status, as this guides treatment decisions 1
- Include all relevant autoantibodies, not just ANA, as they provide prognostic information 1, 3
- Document both active manifestations and cumulative damage to differentiate between current activity and permanent changes 1